These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18082099)

  • 21. Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy.
    Cabiati M; Svezia B; Matteucci M; Botta L; Pucci A; Rinaldi M; Caselli C; Lionetti V; Del Ry S
    PLoS One; 2016; 11(8):e0160110. PubMed ID: 27479215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts.
    Chahine MN; Mioulane M; Sikkel MB; O'Gara P; Dos Remedios CG; Pierce GN; Lyon AR; Földes G; Harding SE
    Cardiovasc Res; 2015 Jan; 105(1):31-43. PubMed ID: 25341891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy.
    Schäfer R; Abraham D; Paulus P; Blumer R; Grimm M; Wojta J; Aharinejad S
    Circulation; 2003 Sep; 108(13):1585-91. PubMed ID: 12963640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy.
    Brodde OE; Vogelsang M; Broede A; Michel-Reher M; Beisenbusch-Schäfer E; Hakim K; Zerkowski HR
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):585-94. PubMed ID: 9554809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy.
    Tarazón E; Roselló-Lletí E; Rivera M; Ortega A; Molina-Navarro MM; Triviño JC; Lago F; González-Juanatey JR; Orosa P; Montero JA; Salvador A; Portolés M
    PLoS One; 2014; 9(3):e90157. PubMed ID: 24599027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of genes participating in cardiomyocyte electrophysiological remodeling via membrane ionic mechanisms and Ca
    Kepenek ES; Ozcinar E; Tuncay E; Akcali KC; Akar AR; Turan B
    Mol Cell Biochem; 2020 Jan; 463(1-2):33-44. PubMed ID: 31520233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.
    Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Lago F; González-Juanatey JR; Portolés M; Rivera M
    PLoS One; 2014; 9(8):e104709. PubMed ID: 25137373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial segmental thickness variability on echocardiography is a highly sensitive and specific marker to distinguish ischemic and non-ischemic dilated cardiomyopathy in new onset heart failure.
    Katikireddy CK; Acharya T
    Int J Cardiovasc Imaging; 2019 May; 35(5):791-798. PubMed ID: 30594979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ca(2+) /calmodulin-dependent protein kinase II equally induces sarcoplasmic reticulum Ca(2+) leak in human ischaemic and dilated cardiomyopathy.
    Fischer TH; Eiringhaus J; Dybkova N; Förster A; Herting J; Kleinwächter A; Ljubojevic S; Schmitto JD; Streckfuß-Bömeke K; Renner A; Gummert J; Hasenfuss G; Maier LS; Sossalla S
    Eur J Heart Fail; 2014 Dec; 16(12):1292-300. PubMed ID: 25201344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear size of myocardial cells in end-stage cardiomyopathies.
    Yan SM; Finato N; Di Loreto C; Beltrami CA
    Anal Quant Cytol Histol; 1999 Apr; 21(2):174-80. PubMed ID: 10560488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts.
    Jana S; Zhang H; Lopaschuk GD; Freed DH; Sergi C; Kantor PF; Oudit GY; Kassiri Z
    J Am Heart Assoc; 2018 Oct; 7(19):e010427. PubMed ID: 30371322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous reduction of myocardial oxidative metabolism in patients with ischemic and dilated cardiomyopathy using C-11 acetate PET.
    Wu YW; Naya M; Tsukamoto T; Komatsu H; Morita K; Yoshinaga K; Kuge Y; Tsutsui H; Tamaki N
    Circ J; 2008 May; 72(5):786-92. PubMed ID: 18441460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy.
    Herpel E; Pritsch M; Koch A; Dengler TJ; Schirmacher P; Schnabel PA
    Histopathology; 2006 May; 48(6):736-47. PubMed ID: 16681691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the nuclear lamins in the pathogenesis of heart failure in patients undergoing cardiac transplantation.
    Cortés R; Roselló-Lletí E; Rivera M; Martínez-Dolz L; Azorín I; Salvador A; Portolés M
    Transplant Proc; 2009; 41(6):2227-30. PubMed ID: 19715882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered protein levels in the isolated extracellular matrix of failing human hearts with dilated cardiomyopathy.
    DeAguero JL; McKown EN; Zhang L; Keirsey J; Fischer EG; Samedi VG; Canan BD; Kilic A; Janssen PM; Delfín DA
    Cardiovasc Pathol; 2017; 26():12-20. PubMed ID: 27837684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy.
    Spänig S; Kellermann K; Dieterlen MT; Noack T; Lehmann S; Borger MA; Garbade J; Barac YD; Emrich F
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31861129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies.
    Thorin E
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):90-8. PubMed ID: 11444506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitral annuloplasty in patients with ischemic versus dilated cardiomyopathy.
    Szalay ZA; Civelek A; Hohe S; Brunner-LaRocca HP; Klövekorn WP; Knez I; Vogt PR; Bauer EP
    Eur J Cardiothorac Surg; 2003 Apr; 23(4):567-72. PubMed ID: 12694777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.